LLY

1,036.37

-0.35%↓

JNJ

243.49

+0.08%↑

ABBV

232.69

+0.55%↑

NVS

166.17

+2.06%↑

MRK

121.6

+0.22%↑

LLY

1,036.37

-0.35%↓

JNJ

243.49

+0.08%↑

ABBV

232.69

+0.55%↑

NVS

166.17

+2.06%↑

MRK

121.6

+0.22%↑

LLY

1,036.37

-0.35%↓

JNJ

243.49

+0.08%↑

ABBV

232.69

+0.55%↑

NVS

166.17

+2.06%↑

MRK

121.6

+0.22%↑

LLY

1,036.37

-0.35%↓

JNJ

243.49

+0.08%↑

ABBV

232.69

+0.55%↑

NVS

166.17

+2.06%↑

MRK

121.6

+0.22%↑

LLY

1,036.37

-0.35%↓

JNJ

243.49

+0.08%↑

ABBV

232.69

+0.55%↑

NVS

166.17

+2.06%↑

MRK

121.6

+0.22%↑

Home・Akcijų sąrašas・Pulse Biosciences Inc

Pulse Biosciences Inc

Uždarymo kaina

SektoriusSveikatos priežiūra

23.53 2.22

Pirkti Parduoti

Apžvalga

Akcijų kainos pasikeitimas

24 val.

Dabar

Min

23.02

Max

24.02

Pagrindiniai rodikliai
By Trading Economics
Pajamos	-217K -19M
Pardavimai	86K 86K
Pelnas, tenkantis vienai akcijai	-0.29
Pelno marža	-22,540.698
Darbuotojai	75
EBITDA	-228K -19M

Rekomendacijos
By TipRanks
Rekomendacijos	Pirkti
12 mėnesių prognozė	+30.38% upside

Dividendai
By Dow Jones
Kitas uždarbis	2026-02-19

Rinkos statistika
By TradingEconomics
Rinkos kapitalizacija	-179M 958M
Ankstesnė atidarymo kaina	21.31
Ankstesnė uždarymo kaina	23.53

Naujienos nuotaikos

By Acuity

45%

55%

135 / 351 reitingas Healthcare

Techninis įvertinimas

By Trading Central

Pasitikėjimas

Very Strong Bearish Evidence

16.59 / 17.17 Palaikymas ir pasipriešinimas

Pulse Biosciences Inc Grafikas

Ankstesni rezultatai nėra patikimas būsimų rezultatų rodiklis.

Susijusios naujienos

2026-02-16 22:17; UTC

Uždarbis

Įsigijimai, susijungimai, perėmimai

BHP 1st Half Net Profit, Dividend Rise; Signs $4.3 Billion Silver Streaming Deal

2026-02-16 23:48; UTC

Rinkos pokalbiai

Global Forex and Fixed Income Roundup: Market Talk

2026-02-16 23:48; UTC

Rinkos pokalbiai

Nikkei May Decline; Prime Minister Takaichi's Policy Steps in Focus -- Market Talk

2026-02-16 23:23; UTC

Įsigijimai, susijungimai, perėmimai

BHP Shares Up 7.0% After Silver Streaming Deal, Profit Beat

2026-02-16 23:20; UTC

Įsigijimai, susijungimai, perėmimai

BHP Exploring Other Infrastructure Deals as It Chases $10 Billion Target - Interview

2026-02-16 22:48; UTC

Įsigijimai, susijungimai, perėmimai

BHP CFO: Brokers Value BHP's Total Stake in Antamina Around $4.5 Billion

2026-02-16 22:48; UTC

Įsigijimai, susijungimai, perėmimai

BHP CFO: Has Desalination, Other Power Assets on Which Deals Could Be Considered

2026-02-16 22:48; UTC

Įsigijimai, susijungimai, perėmimai

BHP CFO: Wants to Make Sure It Does Not Give Up Any Strategic, Operational Control of Assets

2026-02-16 22:48; UTC

Įsigijimai, susijungimai, perėmimai

BHP CFO: Will Allocate Cash From Asset Deals to Growth, Shareholder Returns

2026-02-16 22:47; UTC

Įsigijimai, susijungimai, perėmimai

BHP CFO: Won't Put Deadline on $10 Billion Cash Unlock Target

2026-02-16 22:47; UTC

Įsigijimai, susijungimai, perėmimai

BHP CFO: Bar Very High For Asset Deals

2026-02-16 22:47; UTC

Įsigijimai, susijungimai, perėmimai

BHP CFO: Sees 'Quite a Lot of Opportunities' in Potential Infrastructure Deals

2026-02-16 22:35; UTC

Rinkos pokalbiai

Australian Jobs Data Could Confirm Market Too Tight -- Market Talk

2026-02-16 22:02; UTC

Uždarbis

Įsigijimai, susijungimai, perėmimai

BHP 1H Net Profit, Dividend Rise; Signs $4.3 Billion Silver Streaming Deal

2026-02-16 21:48; UTC

Uždarbis

Įsigijimai, susijungimai, perėmimai

BHP: Optimistic That Economic Backdrop Supportive For Key Commodities

2026-02-16 21:48; UTC

Įsigijimai, susijungimai, perėmimai

Wheaton Precious Metals: Acquisition Immediately Increases Production and Cash Flow Profile

2026-02-16 21:48; UTC

Uždarbis

Įsigijimai, susijungimai, perėmimai

BHP: China's Economy Resilient; India Continues to Outperform

2026-02-16 21:47; UTC

Uždarbis

Įsigijimai, susijungimai, perėmimai

BHP: Streaming, WAIO Power Deals Unlock Over $6 Billion of Cash Combined

2026-02-16 21:47; UTC

Uždarbis

Įsigijimai, susijungimai, perėmimai

BHP: Sees Potential to Unlock Up to $10 Billion From Portfolio, Asset Management

2026-02-16 21:47; UTC

Įsigijimai, susijungimai, perėmimai

Wheaton Precious Metals to Have Combined 67.5% of All the Silver Produced From Antamina, Up From 33.75% Currently

2026-02-16 21:46; UTC

Įsigijimai, susijungimai, perėmimai

Wheaton Precious Metals: Upfront Payment to Be Funded Through Combination of Existing Liquidity and New Financing

2026-02-16 21:46; UTC

Įsigijimai, susijungimai, perėmimai

Wheaton Precious Metals Will Pay BHP Total Upfront Cash Consideration of $4.3B on Closing

2026-02-16 21:46; UTC

Uždarbis

Įsigijimai, susijungimai, perėmimai

BHP Interim Dividend Represents 60% Payout Ratio

2026-02-16 21:46; UTC

Įsigijimai, susijungimai, perėmimai

Wheaton Precious Metals in Definitive Precious Metals Purchase Agreement BHP Subsidiary for Its 33.75% Portion of Silver Produced at Antamina Mine in Peru

2026-02-16 21:45; UTC

Uždarbis

Įsigijimai, susijungimai, perėmimai

BHP: Copper Contributed 51% of 1H Underlying Ebitda

2026-02-16 21:43; UTC

Uždarbis

Įsigijimai, susijungimai, perėmimai

BHP Net Debt $14.69 Billion at Dec. 31, Up 25% On-Year

2026-02-16 21:43; UTC

Uždarbis

Įsigijimai, susijungimai, perėmimai

BHP 1H Net Operating Cash Flow $9.37 Billion, Up 13% On-Year

2026-02-16 21:42; UTC

Uždarbis

Įsigijimai, susijungimai, perėmimai

BHP 1H Underlying Ebitda $15.46 Billion, Up 25% On-Year

2026-02-16 21:42; UTC

Uždarbis

Įsigijimai, susijungimai, perėmimai

BHP Was Expected to Record Underlying Profit of $6.03 Billion According to Visible Alpha

2026-02-16 21:41; UTC

Uždarbis

Įsigijimai, susijungimai, perėmimai

BHP 1H Underlying Profit $6.20 Billion, Up 22% On-Year

Akcijų palyginimas

Kainos pokytis

Pulse Biosciences Inc Prognozė

Kainos tikslas

By TipRanks

30.38% į viršų

12 mėnesių prognozė

Vidutinis 30 USD 30.38%

Aukščiausias 30 USD

Žemiausias 30 USD

Remiantis 1 „Wall Street“ analitikais, siūlančiais 12 mėnesių tikslines Pulse Biosciences Inc kainas – Dist per pastaruosius 3 mėnesius.

Bendras įvertinimas

By TipRanks

Pirkti

1 ratings

Pirkti

Laikyti

Parduoti

Remiantis 1 analitikų, pateikusių Pulse Biosciences Inc akcijų reitingus – Dist per pastaruosius 3 mėnesius.

Techninis įvertinimas

By Trading Central

16.59 / 17.17Palaikymas ir pasipriešinimas

Recent bearish events outweigh bullish events.

Rinkos nuotaikos

By Acuity

135 / 351 reitingas Sveikatos priežiūra

Finansinės naujienos

Pardavimo ir administravimo išlaidos

Veiklos sąnaudos

Ikimokestinis pelnas

Pardavimai

Pardavimo savikaina

Bendrasis pelnas iš pardavimo

Skolų palūkanų išlaidos

EBITDA

Veiklos pelnas

Apie bendrovę Pulse Biosciences Inc

Pulse Biosciences, Inc. operates as a novel bioelectric medicine company. The company offers CellFX System, a tunable, software-enabled, and console-based platform that delivers nano second duration pulses of electrical energy to non-thermally clear targeted cells while sparing adjacent non-cellular tissue to treat a various medical condition by using its Nano-Pulse Stimulation technology. The company was formerly known as Electroblate, Inc. and changed its name to Pulse Biosciences, Inc. in December 2015. Pulse Biosciences, Inc. was incorporated in 2014 and is headquartered in Hayward, California.